COVID-19 Advice for the JCU Community - Last updated: 22 October 2021, 8am (AEST)

TREAD Our Research

Our Research

1.      Clinical trials

Current

  • SURPASS-CVOT: Principal Investigator (multicentre international study) -The Effect of Tirzepatide versus Dulaglutide on Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes
  • DFUT study: Principal Investigator -Clinical and Economic Impact of Telemedicine in Management of Diabetes-Related Foot Ulceration in Rural/Remote areas of North Queensland: A Pilot Study
  • Increased awareness of and access to diabetes and tuberculosis care in New Ireland Province of Papua New Guinea

Completed

  • GIED study: examining the role of vildagliptin on IL-6 regulation in diabetic patients with foot ulcers
  • TECOS – Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes
  • LEADER - Principal investigator - Liraglutide in patients with type 2 diabetes with cardiovascular disease
  • AT. Lantus - Principal investigator - Comparing insulin regimens in complicated type 2 diabetes clients
  • ELIXA: Evaluation of lixisinatide in acute coronary syndrome
  • LANDSCAPE: Comparison of insulin Glargine/Glulisine with mixed insulin
  • The role of oxidised lipids in atheroma formation and metabolic syndrome
  • Understanding macrophage biology associated with atherogenesis
  • Novel markers for identifying cardiovascular risk factors
  • Invitro studies in understanding mechanisms in inflammation associated with diabetic foot ulcers.
  • To improve the efficiency and effectiveness of care for persons with diabetes living in rural/remote areas through improved clinical triage, workflow, and intervention using information and alerts from telemonitoring e-devices
  • To improve clinical outcomes and satisfaction of patients enrolled in the program

2.      Basic science research:

3.      Townsville TeleDiabetes and TeleEndocrinology Network -objectives

Overall, research at the TREAD is directed towards improved understanding and novel treatments for diabetic foot ulcers and metabolic syndrome.